A Multicenter Trial Evaluating the Safety and Efficacy of Cesamet for the Symptomatic Treatment of Chemotherapy-Induced Neuropathic Pain in Patients With Cancer
Phase of Trial: Phase IV
Latest Information Update: 18 Feb 2008
At a glance
- Drugs Nabilone (Primary)
- Indications Cancer pain; Neuropathic pain
- Focus Therapeutic Use
- 18 Feb 2008 The expected completion date for this trial is now 1 Oct 2007, as reported by clinicaltrials.gov.
- 13 Aug 2007 Status change from recruiting to completed.
- 19 Dec 2006 Status change